We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+4.33%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.68B
AUM Growth
-$209M
Cap. Flow
-$341M
Cap. Flow %
-9.26%
Top 10 Hldgs %
13.58%
Holding
1,437
New
112
Increased
524
Reduced
590
Closed
111

Sector Composition

Rank Sector Weight
1 Technology 12.63%
2 Healthcare 11.47%
3 Financials 11.29%
4 Industrials 9.35%
5 Consumer Discretionary 8.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATHN
876
DELISTED
Athenahealth, Inc.
ATHN
$482K 0.01%
3,029
+826
+37% +$122K
CEN
877
DELISTED
Center Coast Brookfield MLP & Energy Infrastructure Fund
CEN
$481K 0.01%
5,406
-270
-5% -$24.9K
UHT
878
Universal Health Realty Income Trust
UHT
$603M
$480K 0.01%
7,508
EMF
879
Templeton Emerging Markets Fund
EMF
$317M
$478K 0.01%
32,500
-2,668
-8% -$41.5K
FPE icon
880
First Trust Preferred Securities and Income ETF
FPE
$6.32B
$478K 0.01%
25,104
-2,594
-9% -$50.2K
KTF
881
DWS Municipal Income Trust
KTF
$346M
$478K 0.01%
43,400
-1,000
-2% -$11.1K
NFG icon
882
National Fuel Gas
NFG
$7.82B
$478K 0.01%
9,020
GG
883
DELISTED
Goldcorp Inc
GG
$477K 0.01%
34,739
+1,111
+3% +$15.4K
BIV icon
884
Vanguard Intermediate-Term Bond ETF
BIV
$28.8B
$476K 0.01%
5,878
-60
-1% -$4.85K
CBOE icon
885
Cboe Global Markets
CBOE
$32.5B
$476K 0.01%
4,572
+708
+18% +$74.8K
LPX icon
886
Louisiana-Pacific
LPX
$5.06B
$476K 0.01%
17,489
+3,142
+22% +$90.5K
TTWO icon
887
Take-Two Interactive
TTWO
$45.4B
$474K 0.01%
4,003
+3
+0.1% +$327
LULU icon
888
lululemon athletica
LULU
$13.5B
$473K 0.01%
3,792
+686
+22% +$73.2K
GSY icon
889
Invesco Ultra Short Duration ETF
GSY
$3.86B
$472K 0.01%
+9,391
New +$472K
TPC
890
Tutor Perini Cor
TPC
$4.41B
$472K 0.01%
25,548
+291
+1% +$5.98K
INDA icon
891
iShares MSCI India ETF
INDA
$6.89B
$471K 0.01%
14,163
-8,378
-37% -$284K
MINT icon
892
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$16.9B
$471K 0.01%
4,640
-1,418
-23% -$144K
MOAT icon
893
VanEck Morningstar Wide Moat ETF
MOAT
$11.9B
$471K 0.01%
10,823
-816
-7% -$34.8K
VAW icon
894
Vanguard Materials ETF
VAW
$2.95B
$469K 0.01%
3,563
+30
+0.8% +$3.99K
IYF icon
895
iShares US Financials ETF
IYF
$4.67B
$466K 0.01%
7,954
+560
+8% +$33.3K
TTE icon
896
TotalEnergies
TTE
$195B
$464K 0.01%
7,669
+880
+13% +$53.9K
CCD
897
Calamos Dynamic Convertible & Income Fund
CCD
$707M
$462K 0.01%
21,412
-399
-2% -$8.35K
EXG icon
898
Eaton Vance Tax-Managed Global Diversified Equity Income Fund
EXG
$2.99B
$461K 0.01%
49,574
+3,185
+7% +$29.6K
FVD icon
899
First Trust Value Line Dividend Fund
FVD
$8.32B
$461K 0.01%
15,221
-205
-1% -$6.16K
VG
900
DELISTED
Vonage Holdings Corporation
VG
$461K 0.01%
35,745
+472
+1% +$5.41K

Similar funds

Oppenheimer & Co's Q2 2018 Portfolio in Review

As of Q2 2018, Oppenheimer & Co held 1,437 positions worth $3.68B, down 5.4% from $3.89B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Oppenheimer & Co withdrew a net $341M in Q2 2018, closing 111 positions and reducing 590 holdings. Its most notable exit was Monsanto Co, an estimated $9.28M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Oppenheimer & Co opened a new position in Thor Industries worth $3.01M.

  • Oppenheimer & Co's largest Q2 2018 buy was Thor Industries: 30,900 shares worth $3.01M.
  • Oppenheimer & Co added most to AT&T in Q2 2018, an estimated $7.02M increase.
  • Oppenheimer & Co's biggest Q2 2018 reduction was Foundation Medicine, Inc., cutting an estimated $63.6M.
  • Oppenheimer & Co fully exited Monsanto Co in Q2 2018, selling an estimated $9.28M.
  • Oppenheimer & Co's ten largest holdings make up 14% of its $3.68B portfolio in Q2 2018.
  • Oppenheimer & Co opened 112 new positions and closed 111 in Q2 2018.
  • Oppenheimer & Co's portfolio value fell 5.4% quarter-over-quarter to $3.68B.

Based on Oppenheimer & Co's 13F filing for Q2 2018, filed 10 Aug 2018.